[2P-0649] Development of next generation CAR-T cell therapies with CRISPR-Cas3 technology

^○Tomoaki Fujii¹, Wang Jinxi¹, Ken Mochizuki¹, Kazuto Yoshimi^{1, 2}, Koji Tamada^{3, 4}, Tomoji Mashimo^{1, 2} (1.Division of Animal Genetics, Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, 2.Division of Genome Engineering, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, The University of Tokyo, 3.Department of Immunology, Yamaguchi University Graduate School of Medicine, 4.Center for Gene and Cell Therapy, Institute of Medical Science, The University of Tokyo)

a . Nucleic Acid Engineering / Genome Editing(5 . Information / System / Technology)